3 Things You Should Know About Immunotherapy in DLBCL

Matt Lunning, Grzegorz S. Nowakowski

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{b19fb4844e434d2c8e2fa7fc4f046cb5,

title = "3 Things You Should Know About Immunotherapy in DLBCL",

author = "Matt Lunning and Nowakowski, {Grzegorz S.}",

year = "2024",

language = "English (US)",

volume = "38",

pages = "478--481",

journal = "Oncology (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "12",

}

TY - JOUR

T1 - 3 Things You Should Know About Immunotherapy in DLBCL

AU - Lunning, Matt

AU - Nowakowski, Grzegorz S.

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85215839414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85215839414&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85215839414

SN - 0890-9091

VL - 38

SP - 478

EP - 481

JO - Oncology (United States)

JF - Oncology (United States)

IS - 12

ER -